(Q38179303)

30 August 2017

title

PET/CT assessment in follicular lymphoma using standardized criteria: central review in the PRIMA study (English)

1 reference

30 August 2017

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24435770%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Gilles Salles

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24435770%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Judith Trotman

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24435770%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Christelle Tychyj-Pinel

1

object named as

Christelle Tychyj-Pinel

1 reference

1 June 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24435770%20AND%20SRC:MED&resulttype=core&format=json

author name string

Fabien Ricard

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24435770%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Marion Fournier

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24435770%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Michel Meignan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24435770%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Thierry Lamy

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24435770%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Pierre Vera

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24435770%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

publication date

17 January 2014

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

30 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24435770%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24435770%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24435770%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

408-415

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24435770%20AND%20SRC:MED&resulttype=core&format=json

Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial.

1 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2441-8

Positron emission tomography-computed tomography (PET-CT) after induction therapy is highly predictive of patient outcome in follicular lymphoma: analysis of PET-CT in a subset of PRIMA trial participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2441-8

Revised response criteria for malignant lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2441-8

Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2441-8

Report on the First International Workshop on Interim-PET-Scan in Lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2441-8

Report on the Second International Workshop on interim positron emission tomography in lymphoma held in Menton, France, 8-9 April 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2441-8

Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2441-8

Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2441-8

Follicular lymphoma international prognostic index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2441-8

Long-term follow-up of patients with newly diagnosed follicular lymphoma in the prerituximab era: effect of response quality on survival--A study from the groupe d'etude des lymphomes de l'adulte

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2441-8

What is remission in follicular lymphoma and what is its relevance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2441-8

Predictive value and diagnostic accuracy of F-18-fluoro-deoxy-glucose positron emission tomography treated grade 1 and 2 follicular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2441-8

Phase II trial of short-course CHOP-R followed by 90Y-ibritumomab tiuxetan and extended rituximab in previously untreated follicular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2441-8

Value of [18F]fluorodeoxyglucose positron emission tomography in the management of follicular lymphoma: the end of a dilemma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2441-8

Diagnostic and prognostic impact of 18F-FDG PET/CT in follicular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2441-8

FDG-PET in the assessment of patients with follicular lymphoma treated by ibritumomab tiuxetan Y 90: multicentric study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2441-8

Predictive role of positron emission tomography in the outcome of patients with follicular lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2441-8

Impact of [(18)F]fluorodeoxyglucose positron emission tomography response evaluation in patients with high-tumor burden follicular lymphoma treated with immunochemotherapy: a prospective study from the Groupe d'Etudes des Lymphomes de l'Adulte and G

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2441-8

Improvement of early 18F-FDG PET interpretation in diffuse large B-cell lymphoma: importance of the reference background.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2441-8

Report on the Third International Workshop on Interim Positron Emission Tomography in Lymphoma held in Menton, France, 26-27 September 2011 and Menton 2011 consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2441-8

Computer-assisted quantitative evaluation of therapeutic responses for lymphoma using serial PET/CT imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2441-8

18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) visualizes follicular lymphoma irrespective of grading

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2441-8

Frequent impact of [18F]fluorodeoxyglucose positron emission tomography on the staging and management of patients with indolent non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2441-8

Utility of FDG-PET scanning in lymphoma by WHO classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2441-8

Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2441-8

Role of fluorine-18 fluoro-deoxyglucose positron emission tomography scan in the evaluation and follow-up of patients with low-grade lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2441-8

Positron emission tomography (PET) for staging low-grade non-Hodgkin's lymphomas (NHL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2441-8

The usefulness of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) and a comparison of (18)F-FDG-pet with (67)gallium scintigraphy in the evaluation of lymphoma: relation to histologic subtypes based on the World Health Organiza

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2441-8

(18)F-FDG avidity in lymphoma readdressed: a study of 766 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2441-8

Impact of [18f] fluorodeoxyglucose positron emission tomography on staging and management of early-stage follicular non-hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2441-8

The Follicular Lymphoma International Prognostic Index (FLIPI) separates high-risk from intermediate- or low-risk patients with advanced-stage follicular lymphoma treated front-line with rituximab and the combination of cyclophosphamide, doxorubicin

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24435770

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24435770

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00259-013-2441-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24435770%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1 reference